
Medical Device Reprocessing Market Report 2026
Global Outlook – By Type (Reprocessing Support And Services, Reprocessing Medical Devices), By Device Category (Critical Devices, Semi-Critical Devices, Non-Critical Devices), By Application (Cardiology, Gastroenterology, Gynecology, Orthopedic, General Surgery, Other Applications), By End-Use (Hospital, Ambulatory Service Centers, Home Healthcare) - Market Size, Trends, And Global Forecast 2026-2035
Medical Device Reprocessing Market Overview
• Medical Device Reprocessing market size has reached to $2.78 billion in 2025 • Expected to grow to $5.91 billion in 2030 at a compound annual growth rate (CAGR) of 16.4% • Growth Driver: Surge In Surgical Procedures Fuels Growth Of Medical Device Reprocessing Market • Market Trend: Advancements In Endoscope Sterilization Technology To Enhance Patient Safety • North America was the largest region in 2025 and Europe is the fastest growing region.What Is Covered Under Medical Device Reprocessing Market?
Medical device reprocessing refers to a procedure performed on used and reusable medical devices to safely reuse them on subsequent patients. Reprocessing is typically performed by specialized healthcare facilities or companies with the equipment, expertise, and protocols to ensure the devices are appropriately cleaned and sterilized. The main types of medical device reprocessing are reprocessing support and services and reprocessing medical devices. Reprocessing support and services refer to the assistance and resources provided to healthcare facilities or companies involved in the reprocessing of medical devices. The distinct types of device categories involved are critical devices, semi-critical devices, and non-critical devices, which are used in several applications, including cardiology, gastroenterology, gynecology, orthopedics, general surgery, and others. These are used by various end-users, such as hospitals, ambulatory service centers, and home healthcare.
What Is The Medical Device Reprocessing Market Size and Share 2026?
The medical device reprocessing market size has grown rapidly in recent years. It will grow from $2.78 billion in 2025 to $3.22 billion in 2026 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to rising healthcare operational costs, early adoption of reusable surgical instruments, hospital initiatives to reduce medical waste, regulatory approvals for reprocessed devices, increased demand for sterilization services.What Is The Medical Device Reprocessing Market Growth Forecast?
The medical device reprocessing market size is expected to see rapid growth in the next few years. It will grow to $5.91 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to growth in sustainable healthcare practices, expansion of outpatient and ambulatory centers, increasing regulatory clarity for reprocessed devices, rising demand for affordable medical procedures, technological improvements in sterilization and validation processes. Major trends in the forecast period include growing adoption of reusable medical devices, increasing emphasis on cost reduction in hospitals, rising focus on infection control and patient safety, expansion of third-party reprocessing service providers, standardization of reprocessing protocols and quality assurance.Global Medical Device Reprocessing Market Segmentation
1) By Type: Reprocessing Support And Services, Reprocessing Medical Devices 2) By Device Category: Critical Devices, Semi-Critical Devices, Non-Critical Devices 3) By Application: Cardiology, Gastroenterology, Gynecology, Orthopedic, General Surgery, Other Applications 4) By End-Use: Hospital, Ambulatory Service Centers, Home Healthcare Subsegments: 1) By Reprocessing Support And Services: Consulting Services, Training And Education, Validation Services, Quality Assurance Services 2) By Reprocessing Medical Devices: Surgical Instruments, Endoscopes, Imaging Equipment, Other Reusable DevicesWhat Is The Driver Of The Medical Device Reprocessing Market?
An increase in surgical procedures is expected to propel the growth of the medical device reprocessing market going forward. Surgical procedures refer to medical treatment that involves making an incision and using tools to cure or repair disease in a living body. Reprocessing involves removing blood, tissue, and other biological waste from equipment and inactivating infectious microorganisms to ensure that it is clean and safe for the patient who will use it next. For instance, in June 2024, American Society of Plastic Surgeons, a US-based non-profit organization management, minimally invasive procedures experienced a 7 percent growth in 2023, exceeding the growth rate of surgical procedures by 2 percent. Therefore, an increase in surgical procedures is driving the growth of the medical device reprocessing industry.Key Players In The Global Medical Device Reprocessing Market
Major companies operating in the medical device reprocessing market are Cardinal Health, Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic PLC, Danaher Corporation, Fresenius Medical Care, Medline Industries Inc., Stryker Corporation, GE Healthcare, Boston Scientific, Fujifilm Medical Systems, Zimmer Biomet, Olympus Corporation, Intuitive Surgical, Hologic, STERIS Healthcare, Getinge AB, Teleflex Inc., Centurion Medical Inc., Vanguard AG, SteriPro, Medivators Inc., Hygia Healthcare LLC, Innovative Health, LUMITOS AG, SureTek Medical, 3M Health Care, ArjoHuntleigh, Northeast ScientificGlobal Medical Device Reprocessing Market Trends and Insights
Major companies operating in the medical device reprocessing market are focusing on technological advancement, such as GI endoscopes compatible with hydrogen peroxide gas plasma sterilization to reduce cross-contamination and enhance patient safety. GI endoscopes compatible with hydrogen peroxide gas plasma sterilization refers to endoscopes designed to withstand sterilization using hydrogen peroxide vapor and low-temperature plasma, ensuring elimination of bacteria, viruses, and spores. For instance, in August 2024, Pentax Medical, a Japan-based medical device company, in collaboration with Advanced Sterilization Products (ASP), a US-based sterilization solutions company, received U.S. Food and Drug Administration (FDA) clearance for a duodenoscope with new sterilization technology. The device features redesigned distal ends and detachable components for thorough cleaning, allowing sterilization to reach hard-to-clean areas and reducing microbial retention. Its unique design ensures compatibility with high-level disinfectants and compliance with updated FDA reprocessing guidelines. Intended for ERCP procedures in hospitals and clinics, it enhances patient safety, lowers infection risk, and streamlines the reprocessing workflow.What Are Latest Mergers And Acquisitions In The Medical Device Reprocessing Market?
In October 2023, Getinge AB, a Sweden-based medical technology company, acquired Healthmark Industries Co. Inc. for an undisclosed amount. Through this acquisition, Getinge AB aims to enhance Getinge's infection control portfolio by integrating Healthmark’s expertise in innovative cleaning and packaging solutions for healthcare providers. Healthmark Industries is a US-based company that specializes in developing and manufacturing products for the cleaning, testing, and validation of medical devices.Regional Outlook
North America was the largest region in the medical device reprocessing market in 2025. Europe is expected to be the fastest-growing region in the medical device reprocessing market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Medical Device Reprocessing Market?
The medical device reprocessing market consists of revenues earned by entities by providing sterilizing, and disinfecting, as well as evaluation and restoration of the used devices. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical device reprocessing market also includes sales of surgical forceps, endoscopes, stethoscopes, catheters, and laryngoscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Medical Device Reprocessing Market Report 2026?
The medical device reprocessing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical device reprocessing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Medical Device Reprocessing Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.22 billion |
| Revenue Forecast In 2035 | $5.91 billion |
| Growth Rate | CAGR of 15.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Device Category, Application, End-Use |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Cardinal Health, Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic PLC, Danaher Corporation, Fresenius Medical Care, Medline Industries Inc., Stryker Corporation, GE Healthcare, Boston Scientific, Fujifilm Medical Systems, Zimmer Biomet, Olympus Corporation, Intuitive Surgical, Hologic, STERIS Healthcare, Getinge AB, Teleflex Inc., Centurion Medical Inc., Vanguard AG, SteriPro, Medivators Inc., Hygia Healthcare LLC, Innovative Health, LUMITOS AG, SureTek Medical, 3M Health Care, ArjoHuntleigh, Northeast Scientific |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
